What has the cloning of the ATM gene told us about ataxia telangiectasia?

International Journal of Radiation Biology

Volumn 73, Issue 4, 1998, Pages 365-371

  Taylor, A M R ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; ATAXIA TELANGIECTASIA; BREAST CANCER; CONFERENCE PAPER; GENE MUTATION; LEUKEMIA; MEIOSIS; MOLECULAR CLONING; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; RADIOSENSITIVITY; SEQUENCE HOMOLOGY;

ANIMALS; ATAXIA TELANGIECTASIA; BREAST NEOPLASMS; CELL CYCLE PROTEINS; CELLS, CULTURED; DNA-BINDING PROTEINS; GENETIC MARKERS; HUMANS; LEUKEMIA, LYMPHOCYTIC; LEUKEMIA, T-CELL, ACUTE; MICE; MUTATION; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; RADIATION TOLERANCE; RADIATION, IONIZING; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA; ATAXIA; ATAXIA TELANGIECTASIA;

EID: 0031953837     PISSN: 09553002     EISSN: None     Source Type: Journal    
DOI: 10.1080/095530098142185     Document Type: Conference Paper

References (57)

1. ATHMA, P., RAPPAPORT, R. and SWIFT, M., 1996, Molecular genotyping shows that ataxia telangiectasia heterozygotes are predisposed to breast cancer. Cancer Gienetics and Cytogenetics, 42, 130-134.
2. BARLOW, C., HIROTSUNE, S., PAYLOR, R., LIYANAGE, M., ECKHAUS, M., COLLINS, F., SHILOH, Y., CRAWLEY, J. N., RIED, T., TAGLE, D. and WYNSHAW-BOVIS, A. 1996, Atm-deficient mice: a paradigm of ataxia-telangiectasia. Cell, 86, 159-171.
3. BASKARAN, R., WOOD, L. D., WHITTAKER, L. L., et al., 1997, Ataxia telangiectasia mutant protein activates c-Abl tyrosinc kinase in response to ionizing radiation. Nature, 387, 516-519.
4. BEAMISH, H. and LAVIN, M. F., 1994, Radiosensitivity in ataxia telangiectasia: anomalies in radiation induced cell cycle delay. International Journal of Radiation Biology, 65, 175-184.
5. BENTLEY, N. J., HOLTZMAN, D. A., FLAGGS, G., KEEGAN, K. S., DEMAGGIO, A., FORD, J. C., HOEKSTRA, M. and CARR, A. M., 1996, The Schizosaccharomyces pombe rod 3 checkpoint. EMBO Journal, 15, 6641-6651.
6. BROWN, E. J., ALBERS, M. W., SHIN, T. B., ICHIKAWA, K., KEITH, C. T., LANE, W. S. and SCHREIBER, S. L., 1994, A mammalian protein targeted by G1 arresting rapamycin-receptor complex. Nature, 369, 756-759.
7. BROWN, K., ZIV, Y., SADANANDAN, S., CHESSA, L., COLLINS, F. S., SHILOH, Y. and TAGLE, D. A., 1997, The ataxia telangiectasia gene product, a constitutively expressed nuclear protein that is not upregulated following genome damage. Proceedings of the National Academy of Sciences of the USA, 94, 1840-1845.
8. BYRD, P. J., MCCONVILLE, C. M., COOPER, P., PARKHILL, J., STANKOVIC, T., MCGUIRE, G. M., THICK, J. A., and TAYLOR, A. M. R. et al., 1996, Mutations revealed by sequencing the 5′ half of the gene for ataxia telangiectasia. Human Molecular Genetics, 5, 145-149.
9. CHEN, G. and LEE, E.-H., 1996, The product of the ATM gene is a 370kDa nuclear phosphoprotein. Journal of Biological Chemistry, 271, 33 693-33 697.
10. CIMPRICH, K. A., SHIN, T. B., KEITH, C. T. and SCHREIBER, S. L., 1996, cDNA cloning and gene mapping of a candidate human cell cycle checkpoint protein. Proceedings of the National Academy of Sciences of the USA, 93, 2850-2855.
11. Cox, R., 1982, A cellular description of the repair defect in ataxia telangiectasia. In Ataxia Telangiectasia - A Cellular and Molecular Link Between Cancer, Neuropathology and Immune Deficiency, edited by B. A. Bridges and D. G. Harnden (Chichester: Wiley), pp. 141-153.
12. DONEHOWER, L. A., HARVEY, M., SLAGLE, B. L., MCARTHUR, M. J., MONTGOMERY, C. A., BUTEI., J. S. and BRADLEY, A., 1992, Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature, 356, 215-221.
13. DUCHAUD, E., RIDET, A., STOPPA-LYONNET, D., JANIN, N., MOUSTACCHI, E. and ROSSELLI, F., 1996, Deregulated apoptosis in ataxia telangiectasia; association with clinical stigmata and radiosensitivity. Cancer Research, 56, 1400-1404.
14. EASTON, D. F., 1994, Cancer risk in A-T heterozygotes. International Journal of Radiation Biology, 66, S177-S182.
15. ELSON, A., WANG, Y., DAUGHERTY, C. J., MORTON, C. C., ZHOU, F., CAMPOS-TORRES, J. and LEDER, P., 1996, Pleiotropic defects in ataxia telangiectasia protein deficient mice. Proceedings of the National Academy of Sciences of the USA, 93, 13 084-13 089.
16. FITZGERALD, M. G., BEAN, J. M., HEGDE, S. R., UNSAL, H., MACDONALD, D. J., HARKIN, D. P., FINKELSTEIN, D. M., ISSELBACHER, K. J. and HABER, D. A., 1997, Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nature Genetics, 15, 307-310.
17. GILAD, S., KHORSAVI, R., SHKEDY, D., et al., 1996, Predominance of null mutations in ataxia-telangiectasia. Human Molecular Genetics, 5, 433-439.
18. GREENWELL, P. W., KRONMAL, S. L., PORTER, S. E., GASSENHUBER, J., OBERMAIER, B. and PETES, T. D., 1995, TEL1, a gene involved in controlling telomere length in S. cerevisiae is homologous to the human ataxia telangiectasia gene. Cell, 82, 823-829.
19. HARTLEY, K. O., GELL, D., SMITH, G. C. M., ZHANG, H., DIVECHA, N., CONELLY, M., ADMON, A., LEES-MILLER, S. P., ANDERSON, C. W. and JACKSON, S. P., 1995, DNA-dependent protein kinase catalytic subunit: a relative of phosphatidylinositol 3-kinase and the ataxia telangiectasia gene product. Cell, 82, 849-856.
20. JUNG, M., KONDRATYEV, A., LEE, S. A., DIMTCHEV, A. and DRITSCHILO, A., 1997, ATM gene product phosphorylates Iκ-B-α. Cancer Research, 57, 24-27.
21. KASTAN, M. B., ZHAN, Q. M., ELDEIRY, W. S., CARRIER, F., JACKS, T., WALSH, W. V., PLUNKETT, B. S., VOGELSTEIN, B. and FORNACE, A. J., 1992, A mammalian cell cycle checkpoint pathway utilising p53 and GADD 45 is defective in ataxia telangiectasia. Cell, 71, 587-597.
22. KIRCHGESSNER, C. U., PATIL, C. K., EVANS, J. W., CARTER, T. and BROWN, J. M., 1995, DNA dependent kinase (p350) is a candidate for murine scid defect. Science, 267, 1178-1182.
23. KEEGAN, K. S., HOLTZMAN, D. A., PLUG, A. W., et al., 1996, The Atr and Atm protein kinases associate with different sites along meiotically pairing chromosomes. Genes and Development, 10, 2423-2437.
24. LAKIN, N. D., WEBER, P., STANKOVIC, T., ROTTINGHAUS, S. T., TAYLOR, A. M. R. and JACKSON, S. P., 1996, Analysis of the ATM protein in wild type and ataxia telangiectasia cells. Oncogene, 13, 2707-2716.
25. LIPKOWITZ, S., STERN, M.-H. and KIRSCH, I. R., 1990, Hybrid T cell receptor genes formed by interlocus recombination in normal and ataxia telangiectasia lymphocytes. Journal of Experimental Medicine, 172, 409-418.
26. LY, X. and LANF., D. P., 1993, Differential induction of transcriptionally active p53 following UV or ionising radiation; defects in chromosome instability syndromes? Cell, 75, 765-778.
27. LYDALL, D. and WEINERT, T., 1996, From DNA damage to cell cycle arrest and suicide: a budding yeast perspective. Current Opinion in Genetics and Development, 6, 4-11.
28. MCCONVILLE, C. M., STANKOVIC, T., BYRD, P. J., MCGUIRE, G., YAO, Q.-Y., LENNOX, G. G. and TAYLOR, A. M. R., 1996, Mutations associated with variant phenotypes in ataxia telangiectasia. American Journal of Human Genetics, 59, 320-330.
29. METCALFE, J. A., PARKHILL, J., BYRD, P. J., CAMPBELL, L., STACEY, M., BIGGS, P. and TAYLOR, A. M. R., 1996, Accelerated telomere shortening in ataxia telangiectasia. Nature Genetics, 13, 350-353.
30. MEYN, M. S., 1995, Ataxia telangiectasia and cellular responses to DNA damage. Cancer Research, 55, 5991-6001.
31. cs) maps to the scid locus. Proceedings of the National Academy of Sciences of the USA, 92, 10 792-10 795.
32. MORGAN, S. E., LOVLY, C., PANDITA, T. K., SHILOH, Y. and KASTAN, M. B., 1997, Fragments of ATM which have dominant-negative or complementing activity. Molecular and Cellular Biology, 17, 2020-2029.
33. MORROW, D. M., TAGLE, D. M., SHILOH, Y., COLLINS, F. S. and HIETER, P., 1995, TEL1, a Saccharomyces cervisiae homolog of the human gene mutated in ataxia telangiectasia, is functionally related to the yeast checkpoint gene MEC1. Cell, 82, 831-840.
34. PAINTER, R. B. and YOUNG, B. R., 1980, Radiosensitivity in ataxia telangiectasia; a new explanation. Proceedings of the National Academy of Sciences of the USA, 77, 7315-7317.
35. SANCHEZ, Y., DESANY, B. A., JONES, W. J., LIU, Q., WANG, B. and ELLEDGE, S. J., 1996, Regulation of RAD53 by the ATM-like kinases MEC1 and TEL1 in yeast cell cycle checkpoint pathways. Science, 271, 357-360.
36. SAVITSKY, K., BAR-SHIRA, A., GILAD, S., ROTMAN, G., ZIV, Y., VANAGAITE, L., TAGLE, D. A., et al., 1995a, A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science, 268, 1749-1753.
37. SAVITSKY, K., SFEZ, S., TAGLE, D. A., ZIV, Y., SARTIEL, A., SHILOH, Y. and ROTMAN, G., 1995b, The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Human Molecular Genetics, 4, 2025-2032.
38. SEDGWICK, R. P. and BODER, F., 1991, Ataxia-telangiectasia. In Handbook of Clinical Neurology: Hereditary Neuropathies and Spinocerebellar Atrophies, Vol 16, edited by J. M. J. V. de Jong (Amsterdam: Elsevier), pp. 347-423.
39. SHAFMAN, T., KHANNA, K. K., KEDAR, P., et al., 1997, Interaction between ATM protein and c-Abl in response to DNA damage. Nature, 387, 520-523.
40. STILGENBAUER, S., SCHAFFNER, C., LITTERST, A., LIEBISCH, P., GILAD, S., BAR-SHIRA, A., JAMES, M. R., LICHTER, P. and DOHNER, H., 1997, Biallelic mutations in the ATM gene in T prolymphocytic leukaemia. Nature Medicine, 3, 1155-1159.
41. SWIFT, M., MORRELL, D., MASSEY, R. B. and CHASE, C. L., 1991, Incidence of cancer in 161 families affected by ataxia-telangiectasia. New England Journal of Medicine, 325, 1831-1836.
42. TAALMAN, R. D. F. M., HUSTINX, T. W. J., WEEMAES, C. M. R., SEEMANOVA, E., SCHMIDT, A. S., PASSARGE, E. and SCHERES, J. M. J. C., 1989, Further delineation of the Nijmegen Breakage Syndrome. American Journal of Medical Genetics, 32, 425-431.
43. TAYLOR, A. M. R., BYRD, P. J., MCCONVILLE, C. M. and THACKER, S., 1994, Genetic and cellular features of ataxia telangiectasia. International Journal of Radiation Biology, 65, 65-70.
44. TAYLOR, A. M. R., HARNDEN, D. G., ARLETT, C. F., HARCOURT, S. A., LEHMANN, A. R., STEVENS, S. and BRIDGES, B. A., 1975, Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity. Nature, 258, 427-428.
45. TAYLOR, A. M. R., HERNANDEZ, D., MCCONVILLE, C. M., WOODS, C. G., STAGEY, M., BIGGS, P., BYRD, P. J., ARLETT, C. F. and SCOTT, D. 1996b, Malignant disease and variations in radiosensitivity in ataxia telangiectasia patients. In Genetic Predisposition to Cancer, edited by R. A. Eeles, B. A. J. Ponder, D. F. Easton and D. Horwich (London: Chapman and Hall), pp. 138-151.
46. TAYLOR, A. M. R., METCALFE, J. A., THICK, J. and MAK, Y. F., 1996a, Leukaemia and lymphoma in ataxia telangiectasia. Blood, 87, 423-438.
47. TELATAR, M., WANG, Z., UDAR, N., LIANG, T., BERNATOWSKA-MATUSZKIEWICZ, E., LAVIN, M., SHILOH, Y., et al., 1996, Ataxia telangiectasia; mutations in ATM cDNA detected by protein-truncation screening. American Journal of Human Genetics, 59, 40-44.
48. THACKER, J., 1994, Cellular radiosensitivity in ataxia telangiectasta. International Journal of Radiation Biology, 66, S87-S96.
49. VORECHOVSKY, I., LUO, L., DYER, M. J. S., CATOVSKY, D., AMLOT, P., YAXLEY, J. C., FORONI, L., HAMMARSTROM, L., WEBSTER, A. D. B. and YUILLE, M. A. R., 1997, Clustering of missense mutations in the ataxia telangiectasia gene in a sporadic T cell leukaemia, Nature Genetics, 17, 96-99.
50. VORECHOVSKY, I., LUO, L., LINDBLOM, A., NEGRINI, M., WEBSTER, D. B., CROCE, C. and HAMMARSTROM, L., 1996, ATM mutations in cancer families. Cancer Research, 56, 4130-4133.
51. WATTERS, D., KHANNA, K. K., BEAMISH, H., et al., 1997, Cellular localisation of the ataxia telangiectasia (ATM) gene product and discrimination between mutated and normal forms. Oncogene, 14, 1911-1921.
52. WESTPHAL, C. H., ROWAN, S., SCHMALTZ, C., ELSON, A., FISHER, D. E. and LEDER, P., 1997, atm and p53 cooperate in apoptosis and suppression of tumorigenesis but not in resistance to acute radiation toxicity. Nature Genetics, 16, 397-401.
53. WRIGHT, J., TERAOKA, S., ONENGUT, S., TOLUN, A., GATTI, R. A., OCHS, H. D. and CONCANNON, P., 1996, A high frequency of distinct ATM mutations in ataxiatelangiectasia. American Journal of Human Genetics, 59, 839-846.
54. XU, Y., ASHLEY, T., BRAINERD, E. E., BRONSON, R. T., MEYN, M. S. and BALTIMORE, D., 1996, Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects and thymic lymphoma. Genes and Development, 10, 2411-2422.
55. XU, Y. and BALTIMORE, D., 1996, Dual roles of ATM in the cellular response to radiation and in cell growth response. Genes and Development, 10, 2401-2410.
56. YUAN, Z.-M., 1996, Role of c-Abl tyrosine kinase in growth arrest response to DNA damage. Nature, 382, 272-274.
57. ZIV, Y., BAR-SHIRA, A., PECKER, I., RUSSELL, P., JORGENSEN, T. J., TSARF, I. and SHILOH, J., 1997, Recombinant ATM protein complements the cellular A-T phenotype. Oncogene, 15, 159-167.